Revolutionary Relief: How Spinal Cord Stimulation is Transforming Lives for Queens Residents with Diabetic Neuropathy
For the millions of Americans living with diabetes, peripheral neuropathy represents one of the most debilitating complications they may face. Roughly 34.2 million Americans, or 10.5% of the U.S. population, have diabetes, and about 25% of the 37 million Americans with diabetes have painful diabetic neuropathy. This condition causes burning, shooting, and stabbing pain in the feet and legs that can make simple activities like walking unbearable. However, a groundbreaking treatment is offering new hope to those suffering from this chronic condition: spinal cord stimulation.
Understanding Diabetic Peripheral Neuropathy
Painful diabetic neuropathy is a common disease that results in significant pain and disability. Painful diabetic peripheral neuropathy (PDPN) is a common complication of diabetes mellitus, and prevalence of PDPN ranges from 10 to 26%. In many patients, the pain is of such intensity that it has a major impact on patients’ health-related quality of life and functional ability, including interference with general activity, mood, mobility, work, social relations, sleep, and enjoyment of life.
Traditional treatments have proven inadequate for many patients. Conventional medical management, which includes pharmacotherapies, is ineffective for many patients. Currently, PDPN can only be treated symptomatically; a variety of medications, alone and in combination, is often only partially effective or is accompanied by unacceptable side effects.
The Science Behind Spinal Cord Stimulation
Spinal cord stimulation is an option that uses a device implanted under the skin that delivers electrical stimulation to the spinal cord to cut off pain signals to the brain, akin to a pacemaker for pain. The treatment involves surgical implantation of electrodes and a power source that delivers electrical current to the spinal cord. This treatment decreases the perception of pain in many chronic pain conditions, such as PDN.
The technology has evolved significantly, with high frequency (10 kHz) SCS delivers paresthesia-free therapy. As was shown in a randomized controlled trial, SENZA-PDN (NCT03228420), 10 kHz SCS is safe and effective for the treatment of painful diabetic neuropathy.
Remarkable Clinical Results
Recent clinical trials have demonstrated the exceptional effectiveness of spinal cord stimulation for diabetic neuropathy. At 6 months, 76% of patients who received spinal cord stimulation reported an improvement of 50% or more in their average pain relief. In comparison, patients who did not receive spinal cord stimulation reported a 2% increase in their average amount of pain.
Even more impressive are the long-term results. At 24 months, 90% of spinal cord stimulation recipients had a 50% or more improvement in average pain relief and 65% had profound pain relief, defined as 80% or more relief. “This shows that pain relief with spinal cord stimulation was durable,” Petersen said.
The treatment also showed unexpected benefits beyond pain relief. “While we were primarily looking for improvement in pain and discomfort, many patients regained sensation in their feet for the first time in years, Mr. May being one of them,” Dr. Lad said. “And when patients can feel their feet, they’re less likely to experience some of the other complications of diabetes like immobility and foot injuries, ulcers, and amputation.”
FDA Approval and Accessibility
The treatment has gained official recognition from medical authorities. Abbott announced that the U.S. Food and Drug Administration (FDA) has approved its Proclaim™ XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes. Thanks in part to the study May participated in, the FDA approved the use of spinal cord stimulation to treat diabetic neuropathy pain in July 2021.
NY Spine Medicine: Leading the Way in Queens
For Queens residents seeking this breakthrough treatment, NY Spine Medicine offers hope and expertise. The core belief of our practice is that surgery should be a last resort for treatment of your pain. We exhaust all possible medical options to help our patients recover from their pain as safely and as painlessly as possible. Our holistic approach encompasses minimally invasive procedures to relieve pain, promote healing, and prevent future injury.
Located at 18 E 48th St Ste 901 New York, NY 10017, NY Spine Medicine has established itself as a leader in pain management. At NY Spine Medicine, we are dedicated to the treatment of pain and spine conditions and utilize the most advanced technology and treatment options available in a brand new, state-of-the-art facility. From the moment you enter our clinic, you will feel the compassion, respect, and caring professionalism of our staff.
The practice’s commitment to innovation is evident in their approach to treatment. Utilizing advanced and innovative treatments for both common and rare painful conditions, tailoring treatment plans to individual patient needs for optimal recovery and pain management. From medical interventions to minimally invasive procedures, we prioritize patient comfort and recovery.
The Treatment Process
For patients considering Spinal Cord Stimulation Queens, the process typically involves two phases. SCS is performed in two separate stages: a trial procedure, followed by a permanent implant if the trial is successful. Each stage takes between one and two hours, and the vast majority of these surgeries are done as an outpatient.
Stage one involves implanting trial electrodes, via small needles, which are then connected to an external battery and programmer. We ask you to try the stimulation at home for a week and assess its ability to provide pain relief. If successful, a permanent set of electrodes are implanted and then connected to a small pacemaker-like device that is inserted under the skin in the chest, abdomen, or back.
Benefits Beyond Pain Relief
The advantages of spinal cord stimulation extend far beyond simple pain management. Pain relief: clinical studies have shown that SCS can provide significant pain relief for DPN patients, improving their overall quality of life. Non-pharmacological treatment: SCS offers an alternative to medications, which can have side effects and may not be suitable for all patients. Personalized therapy: The spinal cord stimulator can be adjusted to meet the specific needs of each patient, ensuring optimal pain relief.
Compared with pain medications, the risks of side effects or complications associated with spinal cord stimulation are minimal. The device is also long-lasting, with May can expect his spinal cord stimulator to last for a long time. After about 10 years, he may need a short, 15-minute procedure to replace the battery, which he charges wirelessly every morning.
A New Era of Hope
For Queens residents struggling with diabetic neuropathy, spinal cord stimulation represents more than just a treatment—it’s a pathway back to an active, fulfilling life. Treatment of PDN with SCS demonstrated success in several high-quality multi-center randomized controlled trials. Based on these results, spinal cord stimulation can be recommended for patients with refractory pain due to diabetic neuropathy.
As one patient shared, “I expected pain relief. I did not expect as much pain relief as I got. And having done all the research, I knew it was going to last.” Now more than three years later, he’s walking miles a day, playing golf as often as possible, and encouraging others to consider spinal cord stimulation.
With the expertise and compassionate care available at NY Spine Medicine, Queens residents no longer need to accept a life limited by diabetic neuropathy pain. This revolutionary treatment offers the promise of restored mobility, reduced dependence on medications, and most importantly, a return to the activities and relationships that make life meaningful.